Evidence map›Paper›PMID 40042042›Full record

ArticleAngewandte Chemie (International ed. in English)2025

Identification of an Activity Selector for the Nitroso-Forming Activity in Bacterial Type-III Copper Enzymes.

Hoa Le Xuan, Felix Panis, Annette Rompel

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Structural insights intoInorganic chemistry frontiers · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hoa Le XuanFakultät für Chemie, Institut für Biophysikalische Chemie, Universität Wien, Josef-Holaubek Platz 2, Vienna, 1090, Austria.
Felix PanisFakultät für Chemie, Institut für Biophysikalische Chemie, Universität Wien, Josef-Holaubek Platz 2, Vienna, 1090, Austria.
Annette RompelFakultät für Chemie, Institut für Biophysikalische Chemie, Universität Wien, Josef-Holaubek Platz 2, Vienna, 1090, Austria.

Funding

Austrian Science Fund 10.55776/P32932Universität Wien
6 · The paper itself

Abstract

O-aminophenol oxidases, a specialized subclass of type-III copper proteins, play a crucial role in the biosynthesis of bioactive nitrosophenols, which display antiretroviral and blood cholesterol-lowering activity. Another related subclass of type-III copper proteins, tyrosinases, closely resemble o-aminophenol oxidases structurally and enzymatically but lack their unique ability to oxidize o-aminophenols into nitrosophenols. To unpuzzle the catalytic disparities of both subclasses, highly conserved amino acid residues in the vicinity of the catalytic center were identified. Notably, the Asn43 residue in the o-aminophenol oxidase from Streptomyces griseus (SgGriF) plays a pivotal role in its nitroso-forming activity. Mutating the Asn43 residue in SgGriF to isoleucine, which is present at the homologous position Ile42 in the tyrosinase from Streptomyces sp. ZL-24 (SzTYR), resulted in the loss of the nitroso-forming activity in SgGriF. Conversely, exchanging Ile42 in SzTYR to asparagine generates nitroso-forming activity in SzTYR. The results presented herein demonstrate the feasibility of converting an o-aminophenol oxidase into a tyrosinase and vice versa through a single amino acid mutation, underscoring the potential of these findings for future applications in medicinal and material sciences.

Indexed as

CopperMonophenol MonooxygenaseNitroso CompoundsOxidoreductasesStreptomyces griseusAminophenolsAminophenolsCopperMonophenol MonooxygenaseNitroso CompoundsOxidoreductasesAminophenolBiotechnologyC‐nitrosationEnzyme engineeringPolyphenol oxidases

Identifiers

PMID40042042
PMCPMC12184298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.